Sources | Names Used |
---|---|
CTRPv2 | BRD-K14844214 |
PharmacoGx | BRD-K14844214 |
Database | Identifier |
---|---|
Smiles: | CC(C)CC#Cc1ccc2c(O[C@@H](CN(C)C(=O)c3cnccn3)[C@H](C)CN([C@H](C)CO)S2(=O)=O)c1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLC25A13 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
mRNA | POLI | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
mRNA | FARSA | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |
mRNA | TOP2A | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
mRNA | SPEN | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
mRNA | SRPRA | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
mRNA | CFHR4 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
mRNA | KAZN | CTRPv2 | pan-cancer | AAC | -0.078 | 0.07 |
mRNA | CCNO | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
mRNA | UPF2 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |